key: cord-0719101-zf7a0d95
authors: Wilson, M. P.; Coulden, R. A.; Low, G.
title: COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging
date: 2020-04-18
journal: Clin Radiol
DOI: 10.1016/j.crad.2020.04.004
sha: 06ccb834413d798d3682ae0a27be857849d6eb4b
doc_id: 719101
cord_uid: zf7a0d95

nan

Correspondence COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging Q2 Sir Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19). SARS-CoV-2 is a single-stranded RNA enveloped virus, which uses the ACE2 receptor for cellular adherence. 1 Most imaging features reported to date associated with COVID-19 have focused on lung imaging findings as respiratory symptomatology is most common 2,3 ; however, ACE2-expressing cells have been shown to be present in a number of other organs including the myocardium, where nearly 10% of cells demonstrate ACE2 expression. 4 The heart has therefore been identified as a high risk site for SARS-CoV-2 infection, particularly in patients with prior cardiac injury, diabetes mellitus, and/or hypertension treated with ACE inhibitors or angiotensin receptor blockers (ARB) where there may be unregulated ACE2 expression. 4, 5 Severe myocarditis has already been reported in patients with COVID-19 6,7 and inflammatory infiltrates in the myocardium have been confirmed on autopsy studies. 8 The high risk for myocardial involvement in patients with COVID-19 has implications for chest imaging. Firstly, as the number of cases continue to rise, COVID-19 may be an increasingly frequent consideration as a potential cause for viral myocarditis on imaging. Secondly, radiologists should be aware that the number of imaging requests for cardiac imaging in patients with suspected or confirmed COVID-19 are likely to increase in order to explore for potential causes of cardiac injury such as coronary artery disease or myocarditis. Approximately 40% of hospitalised COVID-19 infected patients have coronary artery disease and nearly a quarter of critically ill patients can have cardiac injury. 9 Differentiating between acute coronary syndromes related to systemic disease and primary cardiac injury will be clinically important for management as treatment remains supportive at present time. 7 To this end, a specific review for coronary calcification or occult features of ischaemic heart disease on chest computed tomography (CT) should be undertaken. Cardiac magnetic resonance imaging (MRI) could also be considered in patients with suspected or confirmed COVID-19 and with clinical, biochemical, and/or electrocardiography (ECG) changes suggestive of myocardial injury but without an acute coronary syndrome. 

Coronavirus infections d more than just the common cold

Chest imaging appearances of COVID-19 infection

Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)

Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Potential effects of coronaviruses on the cardiovascular system: a review

The authors declare no conflict of interest